Sales and Marketing

Showing 15 posts of 11524 posts found.

NICE rejects GSK’s Tyverb

July 9, 2008 Sales and Marketing

GlaxoSmithKline's Tyverb is the latest high-cost cancer treatment to be rejected by the medicines watchdog NICE. Using the breast cancer …

Lilly acquires SGX Pharma and drug discovery platform

July 9, 2008 Research and Development, Sales and Marketing biotech

Lilly is to buy SGX Pharmaceuticals, a biotech company that specialises in cutting-edge technology which helps drug discovery and design. …

Scottish marine biotech founder wins entrepreneur award

July 8, 2008 Research and Development, Sales and Marketing Scotland, biotech

The chief executive of an innovative marine biotechnology company has been named Scottish entrepreneur of the year in healthcare. Dr …

Latest news from Datamonitor

July 7, 2008 Sales and Marketing

Pharmaceutical companies must adapt to changing market dynamics in 2008Pharma companies face growing competition from generics, increasingly tough pricing and …

Almirall expands its horizons

July 3, 2008 Research and Development, Sales and Marketing Almirall, COPD, Spain

Almirall has been Spain's number one pharmaceutical company for some years, but is still little known outside its home market. …

Shire to buy up German biotech

July 3, 2008 Sales and Marketing MA, biotech

Shire is set to acquire German biotech firm Jerini, in a bid to expand its portfolio of treatments for rare …

AstraZeneca wins vital Seroquel battle

July 3, 2008 Sales and Marketing AZ, generics, psych

Anglo-Swedish pharma company AstraZeneca has scored a vital victory in defending the patent on its blockbuster drug Seroquel. A US …

Pfizer declares revolution in US medical education funding

July 3, 2008 Medical Communications, Sales and Marketing CME, US, ethics

A revolution in the funding of continuing medical education is on the cards after Pfizer declared it would no longer …
nhs60cakeweb

The NHS: Sixty years of conflict and compromise

July 2, 2008 Sales and Marketing Aneurin Bevan, NHS

The headline of the Evening Standard reads: “The Doctors say No! 89% against present plan”. Is this the reaction to …

A faster NICE and a ‘right’ to drug access in NHS Constitution

July 1, 2008 Sales and Marketing NICE

The problem of access to new cancer treatments and other medicines is to be addressed as part of the newly …

Latest news from Datamonitor

June 30, 2008 Sales and Marketing

Can technology diminish reliance on heart transplants?Growing risk factors in an ageing population have driven the rising prevalence of heart …

NICE budget to be ‘significantly increased’

June 27, 2008 Sales and Marketing

The government is to significantly increase NICE's budget to allow it to take on more work, according to the watchdog's …

Global marketing and the shifting balance of power

June 23, 2008 Sales and Marketing US, global, marketing

As a marketer in the international pharmaceutical world, it is very likely that the brand we are responsible for has …
The Gateway to Local Adoption Series

Latest content